search URL:,https://patents.google.com/?assignee=RECRO+PHARMA+INC
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
EP-3090731-B1,Formulations comprising nanoparticulate meloxicam ,"Recro Pharma, Inc.","Eugene R. Cooper, Tuula Ryde, John D. Pruitt, Laura Kline",2003-03-03,2004-02-27,2018-09-19,2018-09-19,https://patents.google.com/patent/EP3090731B1/en,https://patentimages.storage.googleapis.com/98/c6/28/606d53745077b5/imgf0001.png
US-7459283-B2,Nanoparticulate compositions having lysozyme as a surface stabilizer ,Elan Pharma International Limited,"Christian F. Wertz, Niels P. Ryde",2002-02-04,2003-02-04,2008-12-02,2008-12-02,https://patents.google.com/patent/US7459283B2/en,
AU-2010248776-B2,Sublingual dexmedetomidine compositions and methods of use thereof ,"Recro Pharma, Inc.","Geraldine Anne Henwood, John Joseph Koleng Jr., Randall Jerome Mack, Christopher Thomas Sharr",2009-05-15,2010-05-17,2013-06-06,2013-06-06,https://patents.google.com/patent/AU2010248776B2/en,
US-2013072532-A1,Topical transdermal dexmedetomidine compositions and methods of use thereof ,"Recro Pharma, Inc.","Geraldine A. Henwood, Randall J. Mack, Christopher T. Sharr, John J. Koleng, JR.",2010-01-08,2011-01-07,2013-03-21,,https://patents.google.com/patent/US20130072532A1/en,https://patentimages.storage.googleapis.com/85/40/53/b6210d5995effc/US20130072532A1-20130321-D00001.png
US-2018228809-A1,Nanoparticulate Meloxicam Formulations ,"Recro Pharma, Inc.","Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline",2003-03-03,2018-04-11,2018-08-16,,https://patents.google.com/patent/US20180228809A1/en,https://patentimages.storage.googleapis.com/aa/45/43/60e682a08dcf05/US20180228809A1-20180816-D00001.png
AU-2012352528-B2,Intranasal dexmedetomidine compositions and methods of use thereof ,"Recro Pharma, Inc.","Charles Alexander FREYER, Geraldine A. Henwood, John Joseph Koleng Jr., Randall J. Mack, Christopher T. Sharr",2011-12-11,2012-12-11,2017-10-26,2017-10-26,https://patents.google.com/patent/AU2012352528B2/en,
CA-2508335-C,Imidazole derivatives having affinity for alpha 2 receptors activity ,"Orion Corporation, Tomi Jarvinen, Riku Niemi, Juhani Huuskonen, Recro Pharma, Inc.","Tomi Jarvinen, Riku Niemi, Juhani Huuskonen",2002-12-05,2003-12-05,2011-09-13,2011-09-13,https://patents.google.com/patent/CA2508335C/en,
US-9078883-B2,Treatment or prevention of hypotension and shock ,"Recro Pharma, Inc.","Riitta Heino, Tiina Leino, Tarja Lehtimaki",1999-10-29,2013-06-24,2015-07-14,2015-07-14,https://patents.google.com/patent/US9078883B2/en,https://patentimages.storage.googleapis.com/e5/d6/48/c77d0a2aeba496/US09078883-20150714-D00001.png
AU-2003302622-B2,Imidazol derivatives having affinity for alpha 2 receptors activity ,"Recro Pharma, Inc.","Juhani Huuskonen, Tomi Jarvinen, Riku Niemi",2002-12-05,2003-12-05,2010-02-11,2010-02-11,https://patents.google.com/patent/AU2003302622B2/en,
